Jim Young

Health ProfessionsMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration”.

Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration

The Lancet HIV(2023)10.1016/s2352-3018(23)00233-3

N/A

1.0DataRank · unranked

29 citations

Sara Lodi, Roger Logan, Giota Touloumi, Anastasia Antoniadou, Linda Wittkop +25 more

Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study

JAIDS Journal of Acquired Immune Deficiency Syndromes(2015)10.1097/qai.0000000000000662

N/A

0.665DataRank · unranked

83 citations

Yongling Xiao, Erica E. M. Moodie, Michal Abrahamowicz, Marina B. Klein, Enos Bernasconi +7 more

Do contemporary antiretrovirals increase the risk of end‐stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design

Pharmacoepidemiology and Drug Safety(2021)10.1002/pds.5379

N/A

0.241DataRank · unranked

4 citations

Vincent Lo Re, H. Nina Kim, Timothy R. Sterling, Keri N. Althoff, Kelly A. Gebo +7 more

It’s about time: The association between abacavir and cardiovascular disease

Antiviral Therapy(2026)10.1177/13596535261438178

N/A

0DataRank · unranked

0 citations

Patrick R. Lawler, Erica E. M. Moodie, Heiner C. Bucher, Marina B. Klein, Jim Young

Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus

AIDS(2025)10.1097/qad.0000000000004161

N/A

0DataRank · unranked

2 citations

Daniela K van Santen, Juan Berenguer, Inmaculada Jarrín, José M. Miró, Marina B. Klein +21 more

Alternative per-protocol estimates: secondary analyses of data from the Balanced randomised controlled trial

medRxiv(2024)10.1101/2024.10.01.24314731

N/A

0DataRank · unranked

1 citations

Timothy G. Short, Luzius A. Steiner, Salome Dell‐Kuster, Jim Young

Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV

Clinical Infectious Diseases(2025)10.1093/cid/ciaf635

N/A

0DataRank · unranked

0 citations

Mathieu Chalouni, Juan Berenguer, Inmaculada Jarrín, José M. Miró, Marina B. Klein +24 more